Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent RE49353 Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Isan Chen0

Date of Patent

January 3, 2023

Patent Application Number

16998683

Date Filed

August 20, 2020

Patent Citations

US Patent 10702508 Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

US Patent 10729739 Methods of treating prostate cancer with GnRH antagonist

US Patent 10799488 Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer

US Patent 10799489 Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer

US Patent 10849888 Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer

US Patent 10857139 Substituted diazaspiroalkanes as androgen receptor modulators

US Patent 10973870 Methods of treating prostate cancer with GnRH antagonist

US Patent 11160796 Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

...

Patent Primary Examiner

Jerry D Johnson

CPC Code

...

Described herein are methods of treating non-metastatic castrate-resistant prostate cancer with anti-androgens.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent RE49353 Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.